[ { "biomarker_canonical_id": "BB1480", "biomarker_id": "BB1480-1", "biomarker": "decreased levels of MYBPHL", "assessed_biomarker_entity_id": "A2RUH7-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Myosin-binding protein H-like", "specimen": "blood (0000178)", "best_biomarker_role": "risk", "condition": "cardiovascular system disease (DOID:1287)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1480-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1481", "biomarker_id": "BB1481-1", "biomarker": "increased levels of METTL13", "assessed_biomarker_entity_id": "Q8N6R0-5", "assessed_entity_type": "protein", "assessed_biomarker_entity": "eEF1A lysine and N-terminal methyltransferase", "specimen": "blood (0000178)", "best_biomarker_role": "risk", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1481-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1481", "biomarker_id": "BB1481-2", "biomarker": "increased levels of METTL13", "assessed_biomarker_entity_id": "Q8N6R0-5", "assessed_entity_type": "protein", "assessed_biomarker_entity": "eEF1A lysine and N-terminal methyltransferase", "specimen": "blood (0000178)", "best_biomarker_role": "risk", "condition": "lung non-small cell carcinoma (DOID:3908)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1481-2", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1493", "biomarker_id": "BB1493-1", "biomarker": "decreased levels of BLCAP", "assessed_biomarker_entity_id": "P62952-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Apoptosis inducing factor BLCAP", "specimen": "blood (0000178)", "best_biomarker_role": "prognostic", "condition": "urinary bladder cancer (DOID:11054)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1493-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1495", "biomarker_id": "BB1495-1", "biomarker": "increased levels of KLK11", "assessed_biomarker_entity_id": "Q9UBX7-2", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Kallikrein-11", "specimen": "blood (0000178)", "best_biomarker_role": "risk", "condition": "prostate cancer (DOID:10283)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1495-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1495", "biomarker_id": "BB1495-2", "biomarker": "increased levels of KLK11", "assessed_biomarker_entity_id": "Q9UBX7-2", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Kallikrein-11", "specimen": "blood (0000178)", "best_biomarker_role": "risk", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1495-2", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1496", "biomarker_id": "BB1496-1", "biomarker": "increased levels of AGR3", "assessed_biomarker_entity_id": "Q8TD06-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Anterior gradient protein 3", "specimen": "blood (0000178)", "best_biomarker_role": "risk", "condition": "ovarian cancer (DOID:2394)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1496-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1498", "biomarker_id": "BB1498-1", "biomarker": "increased levels of TRAK1", "assessed_biomarker_entity_id": "Q9UPV9-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Trafficking kinesin-binding protein 1", "specimen": "blood (0000178)", "best_biomarker_role": "risk", "condition": "stomach cancer (DOID:10534)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1498-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1512", "biomarker_id": "BB1512-1", "biomarker": "increased levels of SLC3A2", "assessed_biomarker_entity_id": "P08195-2", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Amino acid transporter heavy chain SLC3A2", "specimen": "blood (0000178)", "best_biomarker_role": "diagnostic", "condition": "stomach cancer (DOID:10534)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1512-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1513", "biomarker_id": "BB1513-1", "biomarker": "increased levels of MYBHL", "assessed_biomarker_entity_id": "A2RUH7-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Myosin-binding protein H-like", "specimen": "blood (0000178)", "best_biomarker_role": "diagnostic", "condition": "cardiovascular system disease (DOID:1287)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1513-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1517", "biomarker_id": "BB1517-1", "biomarker": "increased N-glycan level", "assessed_biomarker_entity_id": "G03692CL", "assessed_entity_type": "glycan", "assessed_biomarker_entity": "Disialylated Lewis fucosylated triantennary core fucosylated N-glycan", "specimen": "blood (0000178)", "best_biomarker_role": "diagnostic", "condition": "breast cancer (DOID:1612)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1517-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1520", "biomarker_id": "BB1520-1", "biomarker": "increased MB level", "assessed_biomarker_entity_id": "P02144-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Myoglobin", "specimen": "blood (0000178)", "best_biomarker_role": "monitoring", "condition": "COVID-19 (DOID:0080600)", "component_count": 1, "component_evidence_count": 3, "global_evidence_count": 3, "hit_score": 0.7, "record_id": "BB1520-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1521", "biomarker_id": "BB1521-1", "biomarker": "elevated CEA level", "assessed_biomarker_entity_id": "P06731-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Carcinoembryonic antigen-related cell adhesion molecule 5", "specimen": "blood (0000178)", "best_biomarker_role": "prognostic", "condition": "lung cancer (DOID:1324)", "component_count": 1, "component_evidence_count": 2, "global_evidence_count": 2, "hit_score": 0.5, "record_id": "BB1521-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1524", "biomarker_id": "BB1524-1", "biomarker": "increased AFP level", "assessed_biomarker_entity_id": "P02771-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Alpha-fetoprotein", "specimen": "blood (0000178)", "best_biomarker_role": "diagnostic", "condition": "liver cancer (DOID:3571)", "component_count": 1, "component_evidence_count": 7, "global_evidence_count": 7, "hit_score": 1.5, "record_id": "BB1524-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB1525", "biomarker_id": "BB1525-1", "biomarker": "increased MAGE-1 level", "assessed_biomarker_entity_id": "P43364-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Melanoma-associated antigen 11", "specimen": "blood (0000178)", "best_biomarker_role": "diagnostic", "condition": "liver cancer (DOID:3571)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB1525-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3816", "biomarker_id": "BB3816-1", "biomarker": "absence of glycosylation on CD274", "assessed_biomarker_entity_id": "Q9NZQ7-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Programmed cell death 1 ligand 1", "specimen": "tissue (0000479)", "best_biomarker_role": "", "condition": "triple-receptor negative breast cancer (DOID:0060081)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3816-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3819", "biomarker_id": "BB3819-1", "biomarker": "\u03b2-glucans associated with immunoglobulin M", "assessed_biomarker_entity_id": "P01591-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin J chain", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "candidiasis (DOID:1508)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3819-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3821", "biomarker_id": "BB3821-1", "biomarker": "mannans associated with immunoglobulin M", "assessed_biomarker_entity_id": "P01591-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin J chain", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "candidiasis (DOID:1508)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3821-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3823", "biomarker_id": "BB3823-1", "biomarker": "decreased level of agalactosylated glycan on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "cystinosis (DOID:1064)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3823-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3824", "biomarker_id": "BB3824-1", "biomarker": "decreased level of FA2 on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "cystinosis (DOID:1064)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3824-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3825", "biomarker_id": "BB3825-1", "biomarker": "increased level of galactosylated glycans on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "cystinosis (DOID:1064)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3825-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3826", "biomarker_id": "BB3826-1", "biomarker": "increased level of Tn-MUC1 on MUC1", "assessed_biomarker_entity_id": "P15941-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Mucin-1", "specimen": "tissue (0000479)", "best_biomarker_role": "", "condition": "salivary gland carcinoma (DOID:0050904)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3826-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3826", "biomarker_id": "BB3826-2", "biomarker": "increased level of TnMUC1 on MUC1", "assessed_biomarker_entity_id": "P15941-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Mucin-1", "specimen": "tissue (0000479)", "best_biomarker_role": "", "condition": "lung non-small cell carcinoma (DOID:3908)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3826-2", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3827", "biomarker_id": "BB3827-1", "biomarker": "decreased level of galactosylation on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "lung non-small cell carcinoma (DOID:3908)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3827-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3828", "biomarker_id": "BB3828-1", "biomarker": "decreased level of monosialylation on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "lung non-small cell carcinoma (DOID:3908)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3828-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3829", "biomarker_id": "BB3829-1", "biomarker": "decreased level of bisecting N-acetylglucosamine on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "lung non-small cell carcinoma (DOID:3908)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3829-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3830", "biomarker_id": "BB3830-1", "biomarker": "increased level of agalactosylation on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "lung non-small cell carcinoma (DOID:3908)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3830-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3831", "biomarker_id": "BB3831-1", "biomarker": "decreased level of sialylation on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "lung non-small cell carcinoma (DOID:3908)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3831-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3832", "biomarker_id": "BB3832-1", "biomarker": "decreased level of FS1/FS2 ratio on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood serum (0001977)", "best_biomarker_role": "", "condition": "lung non-small cell carcinoma (DOID:3908)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3832-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3833", "biomarker_id": "BB3833-1", "biomarker": "fucosylated IgG associated with immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "cerebrospinal fluid (0001359)", "best_biomarker_role": "", "condition": "COVID-19 (DOID:0080600)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3833-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3834", "biomarker_id": "BB3834-1", "biomarker": "afucosylated bisecting IgG associated with immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "cerebrospinal fluid (0001359)", "best_biomarker_role": "", "condition": "COVID-19 (DOID:0080600)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3834-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3835", "biomarker_id": "BB3835-1", "biomarker": "sialic acid containing IgG associated with immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "cerebrospinal fluid (0001359)", "best_biomarker_role": "", "condition": "COVID-19 (DOID:0080600)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3835-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3836", "biomarker_id": "BB3836-1", "biomarker": "agalactosylated fucosylated IgG (G0F) associated with immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "cerebrospinal fluid (0001359)", "best_biomarker_role": "", "condition": "COVID-19 (DOID:0080600)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3836-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3838", "biomarker_id": "BB3838-1", "biomarker": "increased level of MUCST on MUC1", "assessed_biomarker_entity_id": "P15941-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Mucin-1", "specimen": " (0008367)", "best_biomarker_role": "", "condition": "luminal breast carcinoma A (DOID:0060548)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3838-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3839", "biomarker_id": "BB3839-1", "biomarker": "increased level of core 1-glycan on MUC1", "assessed_biomarker_entity_id": "P15941-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Mucin-1", "specimen": " (0008367)", "best_biomarker_role": "", "condition": "luminal breast carcinoma A (DOID:0060548)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3839-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3840", "biomarker_id": "BB3840-1", "biomarker": "decreased level of MUCST on MUC1", "assessed_biomarker_entity_id": "P15941-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Mucin-1", "specimen": " (0008367)", "best_biomarker_role": "", "condition": "luminal breast carcinoma A (DOID:0060548)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3840-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3841", "biomarker_id": "BB3841-1", "biomarker": "increased level of MUCT on MUC1", "assessed_biomarker_entity_id": "P15941-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Mucin-1", "specimen": " (0008367)", "best_biomarker_role": "", "condition": "luminal breast carcinoma A (DOID:0060548)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3841-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3842", "biomarker_id": "BB3842-1", "biomarker": "increased level of core 2 on MUC1", "assessed_biomarker_entity_id": "P15941-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Mucin-1", "specimen": " (0008367)", "best_biomarker_role": "", "condition": "luminal breast carcinoma A (DOID:0060548)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3842-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3843", "biomarker_id": "BB3843-1", "biomarker": "increased level of fucosylated N-glycan on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood plasma (0001969)", "best_biomarker_role": "", "condition": "antisynthetase syndrome (DOID:0080744)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3843-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3844", "biomarker_id": "BB3844-1", "biomarker": "decreased level of N-acetylneuraminic acid on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood plasma (0001969)", "best_biomarker_role": "", "condition": "antisynthetase syndrome (DOID:0080744)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3844-1", "record_type": "biomarker" }, { "biomarker_canonical_id": "BB3845", "biomarker_id": "BB3845-1", "biomarker": "decreased level of sialylated IgG on immunoglobulin G", "assessed_biomarker_entity_id": "P01825-1", "assessed_entity_type": "protein", "assessed_biomarker_entity": "Immunoglobulin heavy variable 4-59", "specimen": "blood plasma (0001969)", "best_biomarker_role": "", "condition": "antisynthetase syndrome (DOID:0080744)", "component_count": 1, "component_evidence_count": 1, "global_evidence_count": 1, "hit_score": 0.3, "record_id": "BB3845-1", "record_type": "biomarker" } ]